Immunicum AB (publ) Announces Resignation of Carlos de Sousa as CEO

What we doOur approachPipelineTechnologyPublications
About usExecutive ManagementBoard of DirectorsScientific Advisory Board
News & eventsPress releasesEventsInterviews
Investors
Careers

Back
Immunicum AB (publ) Announces Resignation of Carlos de Sousa as CEO
 8:30:00 AM

Keep reading
Immunicum AB (publ) Announces Positive Preclinical Data on Ilixadencel in Combination with CTLA-4 Immune Checkpoint InhibitorRead